Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study

NeuroImage

Volumn 62, Issue 3, 2012, Pages 1593-1599

  Langkammer, Christian ^a,b   Schweser, Ferdinand ^c   Krebs, Nikolaus ^a,b   Deistung, Andreas ^c   Goessler, Walter ^d   Scheurer, Eva ^a,b   Sommer, Karsten ^c   Reishofer, Gernot ^a   Yen, Kathrin ^e   Fazekas, Franz ^a   Ropele, Stefan ^a   Reichenbach, Jürgen R ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain iron; Myelin; Phase imaging; Post mortem; Quantitative susceptibility mapping

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; AUTOPSY; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; IRON BRAIN LEVEL; MAGNETISM; MALE; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE SUSCEPTIBILITY MAPPING; TISSUE DISTRIBUTION; VALIDATION STUDY; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; BRAIN CHEMISTRY; BRAIN MAPPING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SPECTROPHOTOMETRY, ATOMIC;

EID: 84863522265     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.05.049     Document Type: Article

References (50)

1. Aquino D., Bizzi A., Grisoli M., Garavaglia B., Bruzzone M.G., Nardocci N., Savoiardo M., Chiapparini L. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009, 252:165-172.
2. Barber T.W., Brockway J.A., Higgins L.S. The density of tissues in and about the head. Acta Neurol. Scand. 1970, 46:85-92.
3. Berg D., Youdim M.B. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 2006, 17:5-17.
4. Bilgic B., Pfefferbaum A., Rohlfing T., Sullivan E.V., Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2012, 59:2625-2635.
5. Cheng Y.C., Neelavalli J., Haacke E.M. Limitations of calculating field distributions and magnetic susceptibilities in MRI using a Fourier based method. Phys. Med. Biol. 2009, 54:1169-1189.
6. Connor J.R., Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 1996, 17:83-93.
7. Dawe R.J., Bennett D.A., Schneider J.A., Vasireddi S.K., Arfanakis K. Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation. Magn. Reson. Med. 2009, 61:810-818.
8. Deistung A., Rauscher A., Sedlacik J., Stadler J., Witoszynskyj S., Reichenbach J.R. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn. Reson. Med. 2008, 60:1155-1168.
9. Denk C., Hernandez Torres E., MacKay A., Rauscher A. The influence of white matter fibre orientation on MR signal phase and decay. NMR Biomed. 2011, 24:246-252.
10. Duyn J.H., van Gelderen P., Li T.Q., de Zwart J.A., Koretsky A.P., Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11796-11801.
11. Haacke E.M., Cheng N.Y., House M.J., Liu Q., Neelavalli J., Ogg R.J., Khan A., Ayaz M., Kirsch W., Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 2005, 23:1-25.
12. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 1958, 3:41-51.
13. Khalil M., Langkammer C., Ropele S., Petrovic K., Wallner-Blazek M., Loitfelder M., Jehna M., Bachmaier G., Schmidt R., Enzinger C., Fuchs S., Fazekas F. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011, 77:1691-1697.
14. Langkammer C., Krebs N., Goessler W., Scheurer E., Ebner F., Yen K., Fazekas F., Ropele S. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010, 257:455-462.
15. Langkammer C., Krebs N., Goessler W., Scheurer E., Ebner F., Yen K., Fazekas F., Ropele S. Determinants of R2* relaxation in white matter: insights from postmortem analyses. Proc. Int. Soc. Magn. Reson. Med. 2011, 19:4512.
16. Langkammer C., Krebs N., Goessler W., Scheurer E., Yen K., Fazekas F., Ropele S. Susceptibility induced gray-white matter MRI contrast in the human brain. Neuroimage 2012, 59:1413-1419.
17. Lee J., Shmueli K., Fukunaga M., van Gelderen P., Merkle H., Silva A.C., Duyn J.H. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5130-5135.
18. Lee J., Shmueli K., Kang B.T., Yao B., Fukunaga M., van Gelderen P., Palumbo S., Bosetti F., Silva A.C., Duyn J.H. The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain. Neuroimage 2012, 59:3967-3975.
19. Li L., Leigh J.S. Quantifying arbitrary magnetic susceptibility distributions with MR. Magn. Reson. Med. 2004, 51:1077-1082.
20. Li W., Wu B., Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011, 55:1645-1656.
21. Li W., Wu B., Avram A.V., Liu C. Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings. Neuroimage 2012, 59:2088-2097.
22. Liu C. Susceptibility tensor imaging. Magn. Reson. Med. 2010, 63:1471-1477.
23. Liu C., Li W., Johnson G.A., Wu B. High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage 2011, 56:930-938.
24. Liu T., Khalidov I., de Rochefort L., Spincemaille P., Liu J., Tsiouris A.J., Wang Y. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed. 2011, 24:1129-1136.
25. Liu T., Liu J., de Rochefort L., Spincemaille P., Khalidov I., Ledoux J.R., Wang Y. Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging. Magn. Reson. Med. 2011, 66:777-783.
26. Mitsumori F., Watanabe H., Takaya N. Estimation of brain iron concentration in vivo using a linear relationship between regional iron and apparent transverse relaxation rate of the tissue water at 4.7T. Magn. Reson. Med. 2009, 62:1326-1330.
27. Petridou N., Schafer A., Gowland P., Bowtell R. Phase vs. magnitude information in functional magnetic resonance imaging time series: toward understanding the noise. Magn. Reson. Imaging 2009, 27:1046-1057.
28. Reichenbach J.R. The future of susceptibility contrast for assessment of anatomy and function. Neuroimage 2012, (Epub ahead of print).
29. Reichenbach J.R., Haacke E.M. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 2001, 14:453-467.
30. Salat D.H., Lee S.Y., van der Kouwe A.J., Greve D.N., Fischl B., Rosas H.D. Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. Neuroimage 2009, 48:21-28.
31. Schäfer A., Forstmann B.U., Neumann J., Wharton S., Mietke A., Bowtell R., Turner R. Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping. Hum. Brain Mapp. 2011, Sep 20, http://dx.org/doi/10.1002/hbm.21404, (Epub ahead of print).
32. Schenck J.F. Health and physiological effects of human exposure to whole-body four-tesla magnetic fields during MRI. Ann. N. Y. Acad. Sci. 1992, 649:285-301.
33. Schenck J.F., Dumoulin C.L., Redington R.W., Kressel H.Y., Elliott R.T., McDougall I.L. Human exposure to 4.0-Tesla magnetic fields in a whole-body scanner. Med. Phys. 1992, 19:1089-1098.
34. Schmierer K., Wheeler-Kingshott C.A., Tozer D.J., Boulby P.A., Parkes H.G., Yousry T.A., Scaravilli F., Barker G.J., Tofts P.S., Miller D.H. Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn. Reson. Med. 2008, 59:268-277.
35. Schofield M.A., Zhu Y. Fast phase unwrapping algorithm for interferometric applications. Opt. Lett. 2003, 28:1194-1196.
36. Schweser F., Deistung A., Lehr B.W., Reichenbach J.R. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med. Phys. 2010, 37:5165-5178.
37. Schweser F., Deistung A., Lehr B.W., Reichenbach J.R. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?. Neuroimage 2011, 54:2789-2807.
38. Schweser F., Deistung A., Sommer K., Reichenbach J.R. Disentangling contributions from iron and myelin architecture to brain tissue magnetic susceptibility by using Quantitative Susceptibility Mapping (QSM). Proc. Int. Soc. Magn. Reson. Med. 2012, 20:409.
39. Schweser F., Deistung A., Sommer K., Reichenbach J.R. Improved quantitative susceptibility mapping (QSM) with HEIDI. Proc. Int. Soc. Magn. Reson. Med. 2012, 20:2359.
40. Schweser, F., Deistung, A., Sommer, K., Reichenbach, J.R., in press. Towards real-time quantitative susceptibility mapping: superfast dipole inversion (SDI). Magn. Reson. Med.
41. Schweser F., Deistung A., Sommer K., Reichenbach J.R. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage 2012, 62:2083-2100.
42. Sedlacik J., Rauscher A., Reichenbach J.R. Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels. Magn. Reson. Med. 2007, 58:1035-1044.
43. Shmueli K., de Zwart J.A., van Gelderen P., Li T.Q., Dodd S.J., Duyn J.H. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn. Reson. Med. 2009, 62:1510-1522.
44. Shmueli K., Dodd S.J., Li T.Q., Duyn J.H. The contribution of chemical exchange to MRI frequency shifts in brain tissue. Magn. Reson. Med. 2011, 65:35-43.
45. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23(Suppl. 1):S208-S219.
46. Walsh A.J., Wilman A.H. Susceptibility phase imaging with comparison to R2* mapping of iron-rich deep grey matter. Neuroimage 2011, 57:452-461.
47. Wharton S., Bowtell R. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. Neuroimage 2010, 53:515-525.
48. Wu B., Li W., Guidon A., Liu C. Whole brain susceptibility mapping using compressed sensing. Magn. Reson. Med. 2012, 67:137-147.
49. Yamada N., Imakita S., Sakuma T., Takamiya M. Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology 1996, 198:171-178.
50. Yan S.Q., Sun J.Z., Yan Y.Q., Wang H., Lou M. Evaluation of brain iron content based on magnetic resonance imaging (MRI): comparison among phase value, R2* and magnitude signal intensity. PLoS One 2012, 7:e31748.